SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-045789
Filing Date
2019-08-14
Accepted
2019-08-14 07:48:20
Documents
3
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-16262_28k.htm 8-K 28883
2 EX-99.1 a19-16262_2ex99d1.htm EX-99.1 134846
3 GRAPHIC g162622mmi001.jpg GRAPHIC 6863
  Complete submission text file 0001104659-19-045789.txt   174619
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 191022845
SIC: 2834 Pharmaceutical Preparations